Clofarabine recalls
The FDA has published 1 recall involving Clofarabine since 2017. The latest was reported on 8 Nov 2017. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 8 Nov 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why clofarabine is recalled
Companies
By year
All clofarabine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Clofarabine injection, 20 mg/ Single-Use Vial recalled | Sanofi-Aventis U.S | Packaging Defects | Nationwide |
Should you stop taking Clofarabine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.